Abstract Comparative oncology investigates variation in cancer risk across species by analysing relationships between observed tumour prevalence and factors such as body mass, longevity, life-history traits and mutation rates. These patterns underpin hypotheses on cancer defences, conservation strategies and the evolution of multicellularity, so their robustness is critical. Here, we show that species’ scientific and public popularity substantially biases these trends. Reanalysing published capt